5//SEC Filing
Aegerion Pharmaceuticals, Inc. 5
Accession 0001181431-14-006482
CIK 0001338042operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:01 PM ET
Size
6.6 KB
Accession
0001181431-14-006482
Insider Transaction Report
Form 5
Fitzpatrick Mark J.
Chief Financial Officer
Transactions
- Gift
Common Stock
2013-11-18−100→ 5,750 total - Gift
Common Stock
2013-11-18+100→ 100 total(indirect: By Daughter)
Footnotes (1)
- [F1]This transaction involved a gift of securities by the reporting person to his daughter, who shares reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of his daughter's shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338042
Filing Metadata
- Form type
- 5
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:01 PM ET
- Size
- 6.6 KB